Stock option awards to Glimpse Group, Inc. (GGRP) former director
Rhea-AI Filing Summary
Glimpse Group, Inc. reported that former director Jeffrey D. Enslin, through Perimetre Capital, LLC, acquired two stock option awards. On May 1, 2026 he received 54,375 options with a $0.6900 exercise price that vested immediately. On January 1, 2025 he received 37,500 options with a $2.2500 exercise price, vesting in equal monthly increments from January 31, 2025 through December 31, 2025. Both awards are exercisable into common stock and expire on May 15, 2031.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Enslin Jeffrey D.
Role
Insider
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2, F3 | 54,375 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) F1, F3 | 37,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 91,875 shares (Indirect, By Perimetre Capital, LLC)
Footnotes (3)
- F1. This option vested in equal monthly increments from 1/31/2025 through 12/31/2025.
- F2. This option vested immediately upon grant.
- F3. Perimetre Capital, LLC is an entity owned and managed by Mr. Enslin.
Key Figures
Option grant size: 54,375 options
Exercise price: $0.6900 per share
Option grant size: 37,500 options
+3 more
6 metrics
Option grant size
54,375 options
Stock option grant to Perimetre Capital, LLC dated 2026-05-01
Exercise price
$0.6900 per share
Exercise price for 54,375-option award dated 2026-05-01
Option grant size
37,500 options
Stock option grant to Perimetre Capital, LLC dated 2025-01-01
Exercise price
$2.2500 per share
Exercise price for 37,500-option award dated 2025-01-01
Expiration date
2031-05-15
Expiration for both reported stock option awards
Vesting period
1/31/2025–12/31/2025
Monthly vesting schedule for the 37,500-option grant
Key Terms
Stock Option (Right to Buy), conversion or exercise price, indirect ownership
3 terms
Stock Option (Right to Buy) financial
"Security title is shown as "Stock Option (Right to Buy)" for each award"
conversion or exercise price financial
"Each option grant discloses a specific "conversion or exercise price" per share"
indirect ownership financial
"Ownership type is reported as indirect ownership through Perimetre Capital, LLC"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stock options did Jeffrey D. Enslin receive from Glimpse Group (GGRP) on 2026-05-01?
On May 1, 2026, Jeffrey D. Enslin, via Perimetre Capital, LLC, was granted 54,375 stock options for Glimpse Group common stock at a $0.6900 exercise price. The options vested immediately upon grant and are scheduled to expire on May 15, 2031.
What earlier Glimpse Group (GGRP) stock option grant to Jeffrey D. Enslin is disclosed?
The filing shows a grant of 37,500 stock options on January 1, 2025, with a $2.2500 exercise price. This award vests in equal monthly increments from January 31, 2025 through December 31, 2025, and also expires on May 15, 2031.
How are Jeffrey D. Enslin’s Glimpse Group (GGRP) options held?
Both reported option awards are held indirectly through Perimetre Capital, LLC. A footnote states that Perimetre Capital, LLC is an entity owned and managed by Mr. Enslin, so the options are attributed to that entity rather than to him personally.
Do the Glimpse Group (GGRP) option grants involve a Rule 10b5-1 trading plan?
The filing indicates the grants were not made under a Rule 10b5-1 trading plan. The document-level Rule 10b5-1 checkbox is explicitly unchecked, and there is no footnote stating that the transactions were executed pursuant to any pre-arranged trading arrangement.
When do Jeffrey D. Enslin’s Glimpse Group (GGRP) stock options expire?
Both the 54,375-option award and the 37,500-option award are scheduled to expire on May 15, 2031. This single expiration date applies to each grant, regardless of their different grant dates, exercise prices, and vesting schedules.